Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2026-02-20 @ 6:03 PM
Study NCT ID:
NCT02730351
Status:
COMPLETED
Last Update Posted:
2019-07-16
First Post:
2016-03-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
Sponsor:
GlaxoSmithKline
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Asthma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Fluticasone furoate | View |
| None | activity monitoring | View |
| None | Vilanterol | View |
| None | Cross-over | View |
| None | exercise-induced bronchoconstriction | View |
| None | exercise challenge | View |
| None | double-dummy | View |
| None | asthma | View |
| None | spirometry | View |
| None | fluticasone propionate | View |